Skip to main content
Top
Published in: AIDS and Behavior 11/2015

01-11-2015 | Original Paper

Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults

Authors: Timothy R. Buisker, Mi-Suk Kang Dufour, Janet J. Myers

Published in: AIDS and Behavior | Issue 11/2015

Login to get access

Abstract

Lower nadir CD4 cell counts and higher HIV viral loads are associated with increased risks of adverse events in the progression of HIV disease. In cases where medical records are inaccessible or incomplete, little evidence is available regarding whether nadir CDR cell count or HIV viral load is reliably reported in any patient population. We compare survey data collected from 207 HIV-infected individuals detained in San Francisco jails to data collected from electronic medical records (EMR) kept by the jails and community health providers. The sensitivity of self-reported nadir CD4 cell count less than 200 was 82 % [95 % confidence interval (CI) 68, 88], and the sensitivity of reporting an undetectable most recent HIV viral load was 93 % (95 % CI 84, 97). This suggests that in a highly socially marginalized population, nadir CD4 cell count and most recent HIV viral load are recalled accurately when compared to EMR.
Literature
1.
go back to reference Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS. 2012;4:117–24.PubMedCentralPubMed Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS. 2012;4:117–24.PubMedCentralPubMed
2.
go back to reference Cohen MS, Chen YQ, McCauly M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505.PubMedCentralCrossRefPubMed Cohen MS, Chen YQ, McCauly M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505.PubMedCentralCrossRefPubMed
3.
go back to reference Palepu A, Yip B, Miller C, et al. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001;15(3):423–4.CrossRefPubMed Palepu A, Yip B, Miller C, et al. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001;15(3):423–4.CrossRefPubMed
4.
go back to reference Lucas MG, Chaisson ER, Moore DR. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81–7.CrossRefPubMed Lucas MG, Chaisson ER, Moore DR. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81–7.CrossRefPubMed
5.
go back to reference Moreno A, Perez-Elias MJ, Casado JL, et al. Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes. AIDS. 2001;15:1068–70.CrossRefPubMed Moreno A, Perez-Elias MJ, Casado JL, et al. Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes. AIDS. 2001;15:1068–70.CrossRefPubMed
6.
go back to reference Jensen-Fangel S, Pedersen L, Pedersen C, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis. 2002;35(12):1541–8.CrossRefPubMed Jensen-Fangel S, Pedersen L, Pedersen C, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis. 2002;35(12):1541–8.CrossRefPubMed
7.
go back to reference Palepu A, Tyndall MW, Li K, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80(4):667–75.PubMedCentralCrossRefPubMed Palepu A, Tyndall MW, Li K, et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80(4):667–75.PubMedCentralCrossRefPubMed
8.
go back to reference Mellins CA, Havens JF, McCaskill EO, Leu CS, Brudney K, Chesney MA. Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychol Health Med. 2002;7(4):451–60.CrossRef Mellins CA, Havens JF, McCaskill EO, Leu CS, Brudney K, Chesney MA. Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychol Health Med. 2002;7(4):451–60.CrossRef
9.
go back to reference Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–54.CrossRefPubMed Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–54.CrossRefPubMed
10.
go back to reference Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–94.PubMedCentralCrossRefPubMed Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–94.PubMedCentralCrossRefPubMed
12.
go back to reference Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.PubMedCentralCrossRefPubMed Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.PubMedCentralCrossRefPubMed
13.
go back to reference Cunningham CO, Sohler NL, Heller D, Selwyn PA. Health care access and utilization patterns in unstably housed HIV-infected individuals in New York City. AIDS Patient Care STDS. 2005;19(10):690–5.CrossRefPubMed Cunningham CO, Sohler NL, Heller D, Selwyn PA. Health care access and utilization patterns in unstably housed HIV-infected individuals in New York City. AIDS Patient Care STDS. 2005;19(10):690–5.CrossRefPubMed
14.
go back to reference Tsao JCI, Soto T. Pain in persons living with HIV and comorbid psychological and substance use disorders. Clin J Pain. 2010;25(4):307–12.CrossRef Tsao JCI, Soto T. Pain in persons living with HIV and comorbid psychological and substance use disorders. Clin J Pain. 2010;25(4):307–12.CrossRef
15.
go back to reference Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.PubMedCentralCrossRefPubMed Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.PubMedCentralCrossRefPubMed
16.
go back to reference Cederfjäll C, Langius-Eklöf A, Lidman K, Wredling R. Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients. AIDS Patient Care STDS. 2002;16(12):609–16.CrossRefPubMed Cederfjäll C, Langius-Eklöf A, Lidman K, Wredling R. Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients. AIDS Patient Care STDS. 2002;16(12):609–16.CrossRefPubMed
17.
go back to reference Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. Int J STD AIDS. 2000;11(9):579–85.CrossRefPubMed Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. Int J STD AIDS. 2000;11(9):579–85.CrossRefPubMed
18.
go back to reference Cunningham WE, Rana HM, Shapiro MF, Hays RD. Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease. J Clin Epidemiol. 1997;50(7):829–35.CrossRefPubMed Cunningham WE, Rana HM, Shapiro MF, Hays RD. Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease. J Clin Epidemiol. 1997;50(7):829–35.CrossRefPubMed
19.
go back to reference Kinsler JJ, Cunningham WE, Mohanty S, Wong MD. Are medical records a more reliable and valid source of CD4 count, viral load, and outpatient visit data than self-reports? A comparison with electronic medical records as the gold standard. Health Serv Outcomes Res Methodol. 2008;8(4):187–200.CrossRef Kinsler JJ, Cunningham WE, Mohanty S, Wong MD. Are medical records a more reliable and valid source of CD4 count, viral load, and outpatient visit data than self-reports? A comparison with electronic medical records as the gold standard. Health Serv Outcomes Res Methodol. 2008;8(4):187–200.CrossRef
20.
go back to reference Fisher DG, Reynolds GL, Jaffe A, Johnson ME. Reliability, sensitivity and specificity of self-report of HIV test results. AIDS Care. 2007;19(5):692–6.CrossRefPubMed Fisher DG, Reynolds GL, Jaffe A, Johnson ME. Reliability, sensitivity and specificity of self-report of HIV test results. AIDS Care. 2007;19(5):692–6.CrossRefPubMed
21.
go back to reference Sohler NL, Coleman SM, Cabral H, Naar-King S, Tobias C, Cunningham CO. Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States? AIDS Patient Care STDS. 2009;23(10):837–43.PubMedCentralCrossRefPubMed Sohler NL, Coleman SM, Cabral H, Naar-King S, Tobias C, Cunningham CO. Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States? AIDS Patient Care STDS. 2009;23(10):837–43.PubMedCentralCrossRefPubMed
22.
go back to reference Johnson ME, Fisher DG, Montoya I, et al. Reliability and validity of not-in-treatment drug users’ follow-up self-reports. AIDS Behav. 2000;4(4):373–80.CrossRef Johnson ME, Fisher DG, Montoya I, et al. Reliability and validity of not-in-treatment drug users’ follow-up self-reports. AIDS Behav. 2000;4(4):373–80.CrossRef
23.
go back to reference Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8(2):161–73.PubMedCentralCrossRefPubMed Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8(2):161–73.PubMedCentralCrossRefPubMed
24.
go back to reference CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunisation practices. MMWR. 2012;61(40):816–9. CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunisation practices. MMWR. 2012;61(40):816–9.
25.
go back to reference Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55(4):600–7.CrossRefPubMed Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55(4):600–7.CrossRefPubMed
26.
go back to reference Valcour V, Yee P, Williams AE, et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii aging with HIV cohort. J Neurovirol. 2006;12(5):387–91.CrossRefPubMed Valcour V, Yee P, Williams AE, et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii aging with HIV cohort. J Neurovirol. 2006;12(5):387–91.CrossRefPubMed
27.
go back to reference Boulassel M-R, Chomont N, Pai NP, Gilmore N, Sékaly R-P, Routy J-P. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29–32.CrossRefPubMed Boulassel M-R, Chomont N, Pai NP, Gilmore N, Sékaly R-P, Routy J-P. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29–32.CrossRefPubMed
28.
go back to reference Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.CrossRefPubMed Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.CrossRefPubMed
29.
go back to reference Maclure M, Willett W. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987;126(17):161–9.CrossRefPubMed Maclure M, Willett W. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987;126(17):161–9.CrossRefPubMed
30.
go back to reference Müller R, Büttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.CrossRefPubMed Müller R, Büttner P. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13(23–24):2465–76.CrossRefPubMed
31.
go back to reference Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.PubMed Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.PubMed
32.
go back to reference Myers J, Kang Dufour M-S. Continuity of care for HIV-infected inmates: The San Francisco navigator project [poster]. Third annual academic & health policy conference on correctional health. Atlanta; 2012. Myers J, Kang Dufour M-S. Continuity of care for HIV-infected inmates: The San Francisco navigator project [poster]. Third annual academic & health policy conference on correctional health. Atlanta; 2012.
33.
go back to reference Cohen C. Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen. HIV Clin Trials. 2009;10(2):116–24.CrossRefPubMed Cohen C. Low-level viremia in HIV-1 infection: consequences and implications for switching to a new regimen. HIV Clin Trials. 2009;10(2):116–24.CrossRefPubMed
34.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed
35.
go back to reference Cortina JM. What is coefficient alpha? an examination of theory and applications. J App Psych. 1993;78(1):98–104.CrossRef Cortina JM. What is coefficient alpha? an examination of theory and applications. J App Psych. 1993;78(1):98–104.CrossRef
36.
go back to reference Mariller M, Abramson D, Sobieszczyk M. The validity of self-reported clinical markers and medication regimens: a pilot study. Community health advisory and information network report 2004-06. Columbia University: Mailman School of Public Health: New York; 2006. Mariller M, Abramson D, Sobieszczyk M. The validity of self-reported clinical markers and medication regimens: a pilot study. Community health advisory and information network report 2004-06. Columbia University: Mailman School of Public Health: New York; 2006.
37.
go back to reference Calsyn RJ, Allen G, Morse G, Smith R, Tempelhoff B. Can you trust self-report data provided by homeless mentally ill individuals? Eval Rev. 1993;17(3):353–66.CrossRef Calsyn RJ, Allen G, Morse G, Smith R, Tempelhoff B. Can you trust self-report data provided by homeless mentally ill individuals? Eval Rev. 1993;17(3):353–66.CrossRef
38.
go back to reference Calsyn R, Morse G. Reliability and validity of self-report data of homeless mentally ill individuals. Eval Program Plan. 1997;20(1):47–54.CrossRef Calsyn R, Morse G. Reliability and validity of self-report data of homeless mentally ill individuals. Eval Program Plan. 1997;20(1):47–54.CrossRef
Metadata
Title
Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults
Authors
Timothy R. Buisker
Mi-Suk Kang Dufour
Janet J. Myers
Publication date
01-11-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 11/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1018-x

Other articles of this Issue 11/2015

AIDS and Behavior 11/2015 Go to the issue